GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $50,791,000 | +19.3% | 1,300 | +8.3% | 0.06% | +41.3% |
| Q4 2017 | $42,564,000 | -12.6% | 1,200 | 0.0% | 0.05% | -22.0% |
| Q3 2017 | $48,720,000 | -9.6% | 1,200 | -4.0% | 0.06% | -6.3% |
| Q2 2017 | $53,900,000 | -1.7% | 1,250 | -3.8% | 0.06% | +1.6% |
| Q1 2017 | $54,808,000 | +9.5% | 1,300 | 0.0% | 0.06% | +12.7% |
| Q4 2016 | $50,063,000 | -47.1% | 1,300 | -40.7% | 0.06% | -22.5% |
| Q3 2016 | $94,584,000 | -0.5% | 2,193 | 0.0% | 0.07% | -45.0% |
| Q2 2016 | $95,044,000 | +6.9% | 2,193 | 0.0% | 0.13% | +14.2% |
| Q1 2016 | $88,926,000 | +0.5% | 2,193 | 0.0% | 0.11% | +7.6% |
| Q4 2015 | $88,487,000 | +79.5% | 2,193 | +71.1% | 0.10% | +2.9% |
| Q3 2015 | $49,293,000 | +21.1% | 1,282 | +31.2% | 0.10% | +161.5% |
| Q2 2015 | $40,692,000 | -2.0% | 977 | +8.6% | 0.04% | -4.9% |
| Q1 2015 | $41,535,000 | – | 900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |